| Summary of Stock Option Activity |
The following table summarizes the stock option activity during the years ended December 31, 2019 and 2018:
|
|
|
Shares |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Term
(in Years) |
|
|
Aggregate
Intrinsic
Value |
|
|
Outstanding, January 1, 2018 |
|
|
1,912,980 |
|
|
$ |
3.72 |
|
|
|
8.24 |
|
|
$ |
2,738,704 |
|
|
Granted |
|
|
1,615,200 |
|
|
|
3.64 |
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(52,099 |
) |
|
|
1.47 |
|
|
|
|
|
|
|
|
|
|
Expired/cancelled |
|
|
(124,949 |
) |
|
|
3.23 |
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2018 |
|
|
3,351,132 |
|
|
$ |
3.73 |
|
|
|
8.24 |
|
|
$ |
142,788 |
|
|
Expected to vest, December 31, 2018 |
|
|
2,197,619 |
|
|
$ |
4.17 |
|
|
|
9.19 |
|
|
$ |
- |
|
|
Options exercisable, December 31, 2018 |
|
|
1,153,513 |
|
|
$ |
2.90 |
|
|
|
6.37 |
|
|
$ |
142,788 |
|
|
Outstanding, January 1, 2019 |
|
|
3,351,132 |
|
|
$ |
3.73 |
|
|
|
8.24 |
|
|
$ |
142,788 |
|
|
Granted |
|
|
4,666,728 |
|
|
|
1.85 |
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired/cancelled |
|
|
(2,682,010 |
) |
|
|
2.70 |
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2019 |
|
|
5,335,850 |
|
|
$ |
2.60 |
|
|
|
6.23 |
|
|
$ |
2,866 |
|
|
Expected to vest, December 31, 2019 |
|
|
2,395,265 |
|
|
$ |
1.93 |
|
|
|
9.00 |
|
|
$ |
2,866 |
|
|
Options exercisable, December 31, 2019 |
|
|
2,940,585 |
|
|
$ |
3.15 |
|
|
|
3.98 |
|
|
$ |
— |
|
|
| Summary of Restricted Stock Activity |
A summary of the Company’s restricted stock activity and related information for the years ended December 31, 2019 and 2018 is as follows:
|
|
|
Shares |
|
|
Weighted
Average
Grant Date
Fair Value |
|
|
Nonvested, January 1, 2018 |
|
|
91,576 |
|
|
$ |
2.12 |
|
|
Granted |
|
|
60,000 |
|
|
|
4.75 |
|
|
Vested |
|
|
(149,243 |
) |
|
|
3.18 |
|
|
Forfeited |
|
|
(2,333 |
) |
|
|
2.25 |
|
|
Nonvested, December 31, 2018 |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested, January 1, 2019 |
|
|
— |
|
|
$ |
— |
|
|
Granted |
|
|
— |
|
|
|
— |
|
|
Vested |
|
|
— |
|
|
|
— |
|
|
Forfeited |
|
|
— |
|
|
|
— |
|
|
Nonvested, December 31, 2019 |
|
|
— |
|
|
$ |
— |
|
|
| Summary of Recognized Compensation Cost Related to Employee and Non-employee Stock-Based Compensation Activity |
The Company recognized the following compensation cost related to employee and non-employee stock-based compensation activity for the periods presented below.
|
|
|
|
Year Ended December 31, |
|
|
|
|
|
2019 |
|
|
2018 |
|
|
Research and development |
|
|
$ |
510,923 |
|
|
$ |
392,470 |
|
|
General and administrative |
|
|
|
574,919 |
|
|
|
3,039,392 |
|
|
Total |
|
|
$ |
1,085,842 |
|
|
$ |
3,431,862 |
|
|